Search Results 11-20 of 37197 for Two-phase

  1. A Two-part Phase IIb Trial of Vigil in Ewing's Sarcoma - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  2. Delayed sleep phase - Symptoms and causes - Mayo Clinic

    People with delayed sleep phase have sleep patterns that occur two or more hours later than usual patterns. They go to sleep later and wake later. This ...

  3. A Phase 1/2 Study of MRTX0902 in Solid Tumors With Mutations in the KRAS MAPK Pathway - Mayo Clinic

    A Phase 1/2 Study of MRTX0902 in Solid Tumors With Mutations in the KRAS MAPK Pathway · Overview · Participation eligibility · Participating Mayo Clinic locations.

  4. Phase 2/3 Study Of KPL-387 In Recurrent Pericarditis - Mayo Clinic

    Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines ...

  5. centers-of-excellence

    Overview Tab Title Description Study type Interventional Study phase 2/3 Study IDs Study type Interventional Describes the nature of ...

  6. A Phase 2 Study Of The Safety And Efficacy Of Brepocitinib In Adults With Cutaneous Sarcoidosis (BEACON) - Mayo Clinic

    Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines ...

  7. A Phase 1/2 Study of CYT-0851 in B-Cell Malignancies and Advanced Solid Tumors - Mayo Clinic

    ... Phase 2 dose for evaluation in these patients. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and ...

  8. Phase 1-2 Study of Low Dose ASTX727 (ASTX727 LD) in Lower Risk Myelodysplastic Syndromes - Mayo Clinic

    Phase 2, 80 new subjects will be randomized in a 1:1 ratio into 2 doses/schedules. Participation eligibility. Participant eligibility includes age, gender, type ...

  9. Phase 2 Study for SAR443820 in Participants With Amyotrophic Lateral Sclerosis (ALS) - Mayo Clinic

    Study ACT16970 consists of 2 parts (A and B) as follows: Part A is a 24 week, double blind, placebo controlled part, preceded by a screening period of up to 4 ...

  10. A Phase 2, Multicenter, Randomized Study of AP26113 - Mayo Clinic

    The purpose of this study is to evaluate the efficacy and safety of two different dosing regimens of AP26113 in patients with anaplastic lymphoma kinase (ALK)- ...